11h
MedPage Today on MSNNewer Biologics Tied to Fewer Infections for Older Patients With Psoriatic DiseaseBiologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...
Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...
2d
News-Medical.Net on MSNMediterranean diet shows promise in easing psoriasis, acne, and hidradenitis suppurativaA recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...
Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...
21d
Verywell Health on MSNUnderstanding Scalp Psoriasis and How to Treat ItMedically reviewed by Katlein Franca, MD When psoriasis affects the scalp, it causes thick, silvery-white or gray scales that may be inflamed and itchy. You may also feel burning or other discomfort.
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...
Advancements in biologics, personalized medicine, and rising global prevalence drive the psoriasis treatment market's exponential growth.Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Psoriasis Treatment ...
That risk increased to 97% higher for people using systemic treatment. Cirrhosis and MASLD had the strongest associations with psoriasis. These findings are consistent with those from a 2022 study ...
Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results